AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-80
Results: 1-25/80
In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vessels
Authors: Bocci, G Fasciani, A Danesi, R Viacava, P Genazzani, AR Del Tacca, M
Citation: G. Bocci et al., In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vessels, MOL HUM REP, 7(8), 2001, pp. 771-777
The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer
Authors: Gadducci, A Ferdeghini, M Cosio, S Fanucchi, A Cristofani, R Genazzani, AR
Citation: A. Gadducci et al., The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer, INT J GYN C, 11(4), 2001, pp. 277-282
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea
Authors: Genazzani, AD Bersi, C Luisi, S Fruzzetti, F Malavasi, B Luisi, M Petraglia, F Genazzani, AR
Citation: Ad. Genazzani et al., Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea, J STEROID B, 78(3), 2001, pp. 247-252
Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women
Authors: Florio, P Quirici, B Casarosa, E Lombardi, I Luisi, M Genazzani, AD Petraglia, F Genazzani, AR
Citation: P. Florio et al., Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women, GYNECOL END, 15(5), 2001, pp. 359-366
Serum activin A levels in males and females during pubertal development
Authors: Luisi, S Lombardi, I Florio, P Cobellis, L Iughetti, L Besnasconi, S Genazzani, AR Petraglia, F
Citation: S. Luisi et al., Serum activin A levels in males and females during pubertal development, GYNECOL END, 15(1), 2001, pp. 1-4
Controversial issues in climacteric medicine II - Hormone replacement therapy and cancer
Authors: Genazzani, AR Gadducci, A Gambacciani, M
Citation: Ar. Genazzani et al., Controversial issues in climacteric medicine II - Hormone replacement therapy and cancer, MATURITAS, 40(2), 2001, pp. 117-130
Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy
Authors: Gambacciani, M Ciaponi, M Cappagli, B De Simone, L Orlandi, R Genazzani, AR
Citation: M. Gambacciani et al., Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy, MATURITAS, 39(2), 2001, pp. 125-132
Controversial issues in climacteric medicine (I) cardiovascular disease and hormone replacement therapy. International Menopause Society Expert Workshop, 13-16 October 2000, Royal Society of Medicine, London, UK
Authors: Genazzani, AR
Citation: Ar. Genazzani, Controversial issues in climacteric medicine (I) cardiovascular disease and hormone replacement therapy. International Menopause Society Expert Workshop, 13-16 October 2000, Royal Society of Medicine, London, UK, MATURITAS, 38(3), 2001, pp. 263-271
HRT in the third millennium
Authors: Genazzani, AR Gambacciani, M
Citation: Ar. Genazzani et M. Gambacciani, HRT in the third millennium, MATURITAS, 38, 2001, pp. S49-S55
Malnutrition and cachexia in ovarian cancer patients: Pathophysiology and management
Authors: Gadducci, A Cosio, S Fanucchi, A Genazzani, AR
Citation: A. Gadducci et al., Malnutrition and cachexia in ovarian cancer patients: Pathophysiology and management, ANTICANC R, 21(4B), 2001, pp. 2941-2947
Climacteric complaints, female identity, and sexual dysfunctions
Authors: Nappi, RE Veneroni, F Verde, JB Polatti, F Fignon, A Farina, C Genazzani, AR
Citation: Re. Nappi et al., Climacteric complaints, female identity, and sexual dysfunctions, J SEX MAR T, 27(5), 2001, pp. 567-576
Clinical implications of circulating neurosteroids
Authors: Genazzani, AR Monteleone, P Stomati, M Bernardi, F Cobellis, L Casarosa, E Luisi, M Luisi, S Petraglia, F
Citation: Ar. Genazzani et al., Clinical implications of circulating neurosteroids, INT R NEURO, 46, 2001, pp. 399-419
Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa
Authors: Monteleone, P Luisi, M Colurcio, B Casarosa, E Monteleone, P Ioime, R Genazzani, AR Maj, M
Citation: P. Monteleone et al., Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa, PSYCHOS MED, 63(1), 2001, pp. 62-68
Serum allopregnanolone in women with postpartum "blues"
Authors: Nappi, RE Petraglia, F Luisi, S Polatti, F Farina, C Genazzani, AR
Citation: Re. Nappi et al., Serum allopregnanolone in women with postpartum "blues", OBSTET GYN, 97(1), 2001, pp. 77-80
Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growthfactor-1 secretion in early and late postmenopausal women
Authors: Genazzani, AD Stomati, M Strucchi, C Puccetti, S Luisi, S Genazzani, AR
Citation: Ad. Genazzani et al., Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growthfactor-1 secretion in early and late postmenopausal women, FERT STERIL, 76(2), 2001, pp. 241-248
Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology
Authors: Fasciani, A D'Ambrogio, G Bocci, G Luisi, S Artini, PG Genazzani, AR
Citation: A. Fasciani et al., Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology, FERT STERIL, 75(6), 2001, pp. 1218-1221
Genotype distribution of estrogen receptor-alpha gene polymorphisms in Italian women with surgical uterine leiomyomas
Authors: Massart, F Becherini, L Gennari, L Facchini, V Genazzani, AR Brandi, ML
Citation: F. Massart et al., Genotype distribution of estrogen receptor-alpha gene polymorphisms in Italian women with surgical uterine leiomyomas, FERT STERIL, 75(3), 2001, pp. 567-570
A 12-month clinical investigation with a 24-day regimen containing 15 mu gethinylestradiol plus 60 mu g gestodene with respect to hemostasis and cycle control
Authors: Fruzzetti, F Genazzani, AR Ricci, C De Negri, F Bersi, C Carmassi, F
Citation: F. Fruzzetti et al., A 12-month clinical investigation with a 24-day regimen containing 15 mu gethinylestradiol plus 60 mu g gestodene with respect to hemostasis and cycle control, CONTRACEPT, 63(6), 2001, pp. 303-307
Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women
Authors: Gambacciani, M Ciaponi, M Cappagli, B Genazzani, AR
Citation: M. Gambacciani et al., Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women, AM J OBST G, 185(5), 2001, pp. 1180-1185
High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata
Authors: Fasciani, A D'Ambrogio, G Bocci, G Monti, M Genazzani, AR Artini, PG
Citation: A. Fasciani et al., High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata, MOL HUM REP, 6(1), 2000, pp. 50-54
The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment
Authors: Genazzani, AD Battaglia, C Gamba, O Petraglia, F Malavasi, B Genazzani, AR
Citation: Ad. Genazzani et al., The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment, J AS REPROD, 17(5), 2000, pp. 269-275
Direct vascular effects of estrogens and selective estrogen receptor modulators
Authors: Simoncini, T Genazzani, AR
Citation: T. Simoncini et Ar. Genazzani, Direct vascular effects of estrogens and selective estrogen receptor modulators, CUR OP OBST, 12(3), 2000, pp. 181-187
Polycystic ovary syndrome: a new ultrasonographic and color Doppler pattern
Authors: Battaglia, C Regnani, G Artini, PG Giulini, S Genazzani, AD Genazzani, AR Volpe, A
Citation: C. Battaglia et al., Polycystic ovary syndrome: a new ultrasonographic and color Doppler pattern, GYNECOL END, 14(6), 2000, pp. 417-424
The use of a starting dose of recombinant follicle stimulating hormone forcontrolled ovarian hyperstimulation: a randomized pilot study
Authors: Battaglia, C Regnani, G Petraglia, F Genazzani, AR Artini, PG Volpe, A
Citation: C. Battaglia et al., The use of a starting dose of recombinant follicle stimulating hormone forcontrolled ovarian hyperstimulation: a randomized pilot study, GYNECOL END, 14(5), 2000, pp. 311-315
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause
Authors: Stomati, M Monteleone, P Casarosa, E Quirici, B Puccetti, S Bernardi, F Genazzani, AD Rovati, L Luisi, M Genazzani, AR
Citation: M. Stomati et al., Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause, GYNECOL END, 14(5), 2000, pp. 342-363
Risultati: 1-25 | 26-50 | 51-75 | 76-80